Neurocrine Biosciences Inc (NBIX)
Payables turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 930,800 | 776,400 | 583,300 | 433,300 | 354,062 |
| Payables | US$ in thousands | — | — | — | — | — |
| Payables turnover | — | — | — | — | — |
December 31, 2023 calculation
Payables turnover = Cost of revenue ÷ Payables
= $930,800K ÷ $—K
= —
The payables turnover ratio for Neurocrine Biosciences, Inc. is not available for the years 2019 to 2023 based on the provided data. Payables turnover ratio is a financial metric that evaluates how effectively a company manages its accounts payable by comparing the amount of purchases made on credit to the average accounts payable balance.
Without the specific data for the ratio, it is challenging to assess Neurocrine Biosciences, Inc.'s efficiency in paying its suppliers and managing its trade credit effectively. It would be beneficial to calculate the payables turnover ratio for these years using the formula:
Payables Turnover Ratio = Cost of Goods Sold / Average Accounts Payable
This ratio provides insights into the company's ability to settle its short-term obligations and its relationship with suppliers. Further analysis and comparison with industry benchmarks would help in understanding Neurocrine Biosciences, Inc.'s payment efficiency and financial health.
Peer comparison
Dec 31, 2023